2023
DOI: 10.17116/jnevro20231230118
|View full text |Cite
|
Sign up to set email alerts
|

Gut microbiota in patients with relapsing-remitting multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 44 publications
0
1
0
Order By: Relevance
“…Using the multi-species probiotic ( Lactobacillus species, Bifidobacterium species , and Streptococcus species ) for two months and twice a day has been shown to counteract microbial changes and have anti-inflammatory features [ 105 ]. These findings from animal and human clinical studies suggest that GM have a significant impact on MS physiopathology [ 106 ]. However, the current focus is on how to successfully modify the GM as an intervention to prevent relapse and symptoms of MS to a greater extent and to cure the disease.…”
Section: Neurological Disorders and Gbamentioning
confidence: 99%
“…Using the multi-species probiotic ( Lactobacillus species, Bifidobacterium species , and Streptococcus species ) for two months and twice a day has been shown to counteract microbial changes and have anti-inflammatory features [ 105 ]. These findings from animal and human clinical studies suggest that GM have a significant impact on MS physiopathology [ 106 ]. However, the current focus is on how to successfully modify the GM as an intervention to prevent relapse and symptoms of MS to a greater extent and to cure the disease.…”
Section: Neurological Disorders and Gbamentioning
confidence: 99%